These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32198907)

  • 1. Comparing prenatal screening experiences of Icelandic women who received false-positive and true-negative first-trimester combined screening results in Iceland in 2012-2016.
    Thorolfsdottir E; Lunde Å; Stefansdottir V; Hjartardottir H; Rut Haraldsdottir K
    J Genet Couns; 2020 Aug; 29(4):644-657. PubMed ID: 32198907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing non-invasive prenatal testing (NIPT) in the Netherlands: An interview study exploring opinions about and experiences with societal pressure, reimbursement, and an expanding scope.
    Bakkeren IM; Kater-Kuipers A; Bunnik EM; Go ATJI; Tibben A; de Beaufort ID; Galjaard RH; Riedijk SR
    J Genet Couns; 2020 Feb; 29(1):112-121. PubMed ID: 31710169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for chromosomal abnormalities by first trimester combined screening and noninvasive prenatal testing.
    Kagan KO; Hoopmann M; Hammer R; Stressig R; Kozlowski P
    Ultraschall Med; 2015 Feb; 36(1):40-6. PubMed ID: 25255236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
    Maxwell S; Dickinson JE; Murch A; O'Leary P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening in the era of non-invasive prenatal testing: a Nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice.
    Yang L; Tan WC
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):579. PubMed ID: 33004009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
    Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
    Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
    Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
    Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
    Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results.
    van Schendel RV; Page-Christiaens GCML; Beulen L; Bilardo CM; de Boer MA; Coumans ABC; Faas BHW; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MVE; Oepkes D; Pajkrt E; Henneman L;
    J Genet Couns; 2017 Dec; 26(6):1348-1356. PubMed ID: 28667567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.
    Fairbrother G; Johnson S; Musci TJ; Song K
    Prenat Diagn; 2013 Jun; 33(6):580-3. PubMed ID: 23494956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.
    Li SW; Barrett AN; Gole L; Tan WC; Biswas A; Tan HK; Choolani M
    Singapore Med J; 2015 Jan; 56(1):47-52. PubMed ID: 25640099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of noninvasive prenatal testing at a large academic referral center.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.
    Song K; Musci TJ; Caughey AB
    J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1180-5. PubMed ID: 23356557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.
    Oepkes D; Page-Christiaens GC; Bax CJ; Bekker MN; Bilardo CM; Boon EM; Schuring-Blom GH; Coumans AB; Faas BH; Galjaard RH; Go AT; Henneman L; Macville MV; Pajkrt E; Suijkerbuijk RF; Huijsdens-van Amsterdam K; Van Opstal D; Verweij EJ; Weiss MM; Sistermans EA;
    Prenat Diagn; 2016 Dec; 36(12):1083-1090. PubMed ID: 27750376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands.
    Willems PJ; Dierickx H; Vandenakker E; Bekedam D; Segers N; Deboulle K; Vereecken A
    Facts Views Vis Obgyn; 2014; 6(1):7-12. PubMed ID: 25009720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.